We are live on ! Find out more
TCA

Taconic Capital Advisors Portfolio holdings

AUM $229M
1-Year Est. Return 110.07%
This Fund
S&P 500
This Quarter Est. Return
+12.67%
1 Year Est. Return
+110.07%
3 Year Est. Return
+248.78%
5 Year Est. Return
+339.19%
10 Year Est. Return
+1,217.17%
AUM
$2.47B
AUM Growth
+$873M
Cap. Flow
+$704M
Cap. Flow %
28.46%
Top 10 Hldgs %
83.39%
Holding
64
New
25
Increased
7
Reduced
8
Closed
19

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$93.8M
2
MSFT icon
Microsoft
MSFT
+$80.8M
3
JNJ icon
Johnson & Johnson
JNJ
+$67.8M
4
NKE icon
Nike
NKE
+$56.6M
5
DIS icon
Walt Disney
DIS
+$55.8M

Sector Composition

Rank Sector Weight
1 Healthcare 17.83%
2 Consumer Discretionary 8.05%
3 Financials 7.52%
4 Technology 5.43%
5 Communication Services 3.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIIB icon
26
Biogen
BIIB
$30.9B
$8.9M 0.36%
+30,000
New +$8.32M
GE icon
27
GE Aerospace
GE
$364B
$8.63M 0.35%
155,172
+10,031
+7% +$518K
DLR icon
28
Digital Realty Trust
DLR
$69.6B
$8.46M 0.34%
+70,670
New +$8.7M
MPC icon
29
Marathon Petroleum
MPC
$90.1B
$8.13M 0.33%
+135,000
New +$8.45M
CVS icon
30
CALL
CVS Health
CVS
$135B
$7.43M 0.3%
100,000
-50,000
-33% -$3.51M
GNW icon
31
Genworth Financial
GNW
$3.86B
$7.15M 0.29%
1,625,000
+600,000
+59% +$2.52M
VTRS icon
32
Viatris
VTRS
$20.8B
$7.04M 0.28%
350,000
+50,000
+17% +$930K
CCO icon
33
Clear Channel Outdoor Holdings
CCO
$1.22B
$6.38M 0.26%
2,230,000
+380,000
+21% +$962K
MPC icon
34
CALL
Marathon Petroleum
MPC
$90.1B
$6.03M 0.24%
+100,000
New +$6.26M
MOH icon
35
Molina Healthcare
MOH
$10.4B
$4.07M 0.16%
+30,000
New +$3.78M
GE icon
36
CALL
GE Aerospace
GE
$364B
$3.35M 0.14%
60,191
-40,127
-40% -$2.07M
ALXN
37
DELISTED
Alexion Pharmaceuticals
ALXN
$3.25M 0.13%
+30,000
New +$3.21M
PTON icon
38
Peloton Interactive
PTON
$2.85B
$2.06M 0.08%
+72,416
New +$1.95M
OIBR.C
39
DELISTED
OI S.A. American Depositary Shares, each representing five shares of common stock
OIBR.C
$1.77M 0.07%
1,900,000
NVST icon
40
Envista
NVST
$4.62B
$1.48M 0.06%
+50,000
New +$1.42M
AR icon
41
Antero Resources
AR
$10.9B
$855K 0.03%
+300,000
New +$766K
ABBV icon
42
CALL
AbbVie
ABBV
$465B
-200,000
Closed -$15.1M
AMZN icon
43
Amazon
AMZN
$2.44T
-600,000
Closed -$52.1M
C icon
44
Citigroup
C
$213B
-200,000
Closed -$13.8M
GOOG icon
45
Alphabet (Google) Class C
GOOG
$4.11T
-440,000
Closed -$26.8M
GOOGL icon
46
Alphabet (Google) Class A
GOOGL
$4.12T
-2,300,000
Closed -$140M
INVA icon
47
Innoviva
INVA
$1.6B
-150,000
Closed -$1.58M
LOW icon
48
Lowe's Companies
LOW
$121B
-150,000
Closed -$16.5M
META icon
49
Meta Platforms (Facebook)
META
$1.49T
-230,000
Closed -$41M
MO icon
50
Altria Group
MO
$125B
-35,000
Closed -$1.43M

Similar funds

Taconic Capital Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, Taconic Capital Advisors held 64 positions worth $2.47B, up 55% from $1.6B the previous quarter. Its ten largest holdings account for 83% of the portfolio.

Taconic Capital Advisors deployed $704M of net new capital in Q4 2019, opening 25 new positions and adding to 7 existing holdings. Its largest new stake was Alibaba: 500,000 shares worth $106M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 40% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Allergan plc, an estimated $42.4M trimmed.

  • Taconic Capital Advisors's largest Q4 2019 buy was Alibaba: 500,000 shares worth $106M.
  • Taconic Capital Advisors added most to T-Mobile US in Q4 2019, an estimated $6.25M increase.
  • Taconic Capital Advisors's biggest Q4 2019 reduction was Allergan plc, cutting an estimated $42.4M.
  • Taconic Capital Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $319M.
  • Taconic Capital Advisors's ten largest holdings make up 83% of its $2.47B portfolio in Q4 2019.
  • Taconic Capital Advisors opened 25 new positions and closed 19 in Q4 2019.
  • Taconic Capital Advisors's portfolio value rose 55% quarter-over-quarter to $2.47B.

Based on Taconic Capital Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.